1. Home
  2. BDSX vs TELA Comparison

BDSX vs TELA Comparison

Compare BDSX & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • TELA
  • Stock Information
  • Founded
  • BDSX 2005
  • TELA 2012
  • Country
  • BDSX United States
  • TELA United States
  • Employees
  • BDSX N/A
  • TELA N/A
  • Industry
  • BDSX Precision Instruments
  • TELA Medical/Dental Instruments
  • Sector
  • BDSX Health Care
  • TELA Health Care
  • Exchange
  • BDSX Nasdaq
  • TELA Nasdaq
  • Market Cap
  • BDSX 53.0M
  • TELA 47.1M
  • IPO Year
  • BDSX 2020
  • TELA 2019
  • Fundamental
  • Price
  • BDSX $7.19
  • TELA $1.19
  • Analyst Decision
  • BDSX Strong Buy
  • TELA Buy
  • Analyst Count
  • BDSX 5
  • TELA 3
  • Target Price
  • BDSX $32.50
  • TELA $3.42
  • AVG Volume (30 Days)
  • BDSX 322.6K
  • TELA 279.2K
  • Earning Date
  • BDSX 11-03-2025
  • TELA 11-13-2025
  • Dividend Yield
  • BDSX N/A
  • TELA N/A
  • EPS Growth
  • BDSX N/A
  • TELA N/A
  • EPS
  • BDSX N/A
  • TELA N/A
  • Revenue
  • BDSX $80,173,000.00
  • TELA $77,055,000.00
  • Revenue This Year
  • BDSX $19.04
  • TELA $25.72
  • Revenue Next Year
  • BDSX $26.39
  • TELA $22.03
  • P/E Ratio
  • BDSX N/A
  • TELA N/A
  • Revenue Growth
  • BDSX 22.29
  • TELA 12.24
  • 52 Week Low
  • BDSX $3.44
  • TELA $0.86
  • 52 Week High
  • BDSX $32.20
  • TELA $3.20
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 49.20
  • TELA 41.16
  • Support Level
  • BDSX $7.42
  • TELA $0.93
  • Resistance Level
  • BDSX $8.52
  • TELA $1.25
  • Average True Range (ATR)
  • BDSX 0.85
  • TELA 0.14
  • MACD
  • BDSX -0.05
  • TELA -0.01
  • Stochastic Oscillator
  • BDSX 37.11
  • TELA 50.39

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: